Rheumatoid factor

Results: 141



#Item
51Clinical and epidemiological research EXTENDED REPORT Application of the 2010 ACR/EULAR classification criteria in patients with very early inflammatory

Clinical and epidemiological research EXTENDED REPORT Application of the 2010 ACR/EULAR classification criteria in patients with very early inflammatory

Add to Reading List

Source URL: www.ncbi.nlm.nih.gov

Language: English
52Label - Etanercept (Enbrel), Immunex Corporation

Label - Etanercept (Enbrel), Immunex Corporation

Add to Reading List

Source URL: www.fda.gov

Language: English
53PROTOCOL 588: OVERALL ASSESSMENT • • • •

PROTOCOL 588: OVERALL ASSESSMENT • • • •

Add to Reading List

Source URL: osp.od.nih.gov

Language: English - Date: 2013-12-16 11:01:39
54ENBREL® (etanercept) DESCRIPTION ENBREL (etanercept) is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to th

ENBREL® (etanercept) DESCRIPTION ENBREL (etanercept) is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to th

Add to Reading List

Source URL: www.fda.gov

Language: English
55Etanercept Enbrel[removed]package insert

Etanercept Enbrel[removed]package insert

Add to Reading List

Source URL: www.fda.gov

Language: English
56About the Results How long will it take for my results? Test results for a single sample will be available approximately two weeks after your sample collection. How do I access my results?

About the Results How long will it take for my results? Test results for a single sample will be available approximately two weeks after your sample collection. How do I access my results?

Add to Reading List

Source URL: www.lifelabs.com

Language: English - Date: 2014-10-17 12:26:07
571)l:I’AKTXIKNT OF HFALTH & HUMAN SERVICES Public Health Service Food and Drug Administration Center foeBiologicsEvaluationand Research. HFM-215

1)l:I’AKTXIKNT OF HFALTH & HUMAN SERVICES Public Health Service Food and Drug Administration Center foeBiologicsEvaluationand Research. HFM-215

Add to Reading List

Source URL: www.fda.gov

Language: English
58Intra-articular Administration of a Recombinant Adeno-Associated Vector containing a TNF-a Antagonist Gene in Inflammatory Arthritis

Intra-articular Administration of a Recombinant Adeno-Associated Vector containing a TNF-a Antagonist Gene in Inflammatory Arthritis

Add to Reading List

Source URL: osp.od.nih.gov

Language: English - Date: 2014-01-09 11:14:34
59Rheumatoid Arthritis and the Role of Tumor Necrosis Factor Inhibitors NIH Recombinant DNA Advisory Committee September 17, 2007

Rheumatoid Arthritis and the Role of Tumor Necrosis Factor Inhibitors NIH Recombinant DNA Advisory Committee September 17, 2007

Add to Reading List

Source URL: osp.od.nih.gov

Language: English - Date: 2013-12-10 14:00:31
60On September 17th, the Recombinant DNA Advisory Committee undertook a review of the death of a participant on a gene transfer trial for rheumatoid arthritis, OBA protocol 705 entitled A Phase I/II Study of Repeat Intra-A

On September 17th, the Recombinant DNA Advisory Committee undertook a review of the death of a participant on a gene transfer trial for rheumatoid arthritis, OBA protocol 705 entitled A Phase I/II Study of Repeat Intra-A

Add to Reading List

Source URL: osp.od.nih.gov

Language: English - Date: 2013-12-10 13:57:32